Position in NVAX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$292,576
-$6,022,424 QoQ
Shares Held
35,943
-92.8% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tidal Investments LLC holds $326,523,942 across 90 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
95,685 | $47,529,610 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
43,896 | $27,370,911 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
109,096 | $20,431,498 | |
| 4 | EXEL |
Exelixis, Inc.
|
375,316 | $20,420,943 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
190,305 | $14,895,171 | |
| 6 | INCY |
Incyte Corp
|
102,834 | $11,657,262 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
33,541 | $10,096,847 | |
| 8 | COGT |
Cogent Biosciences, Inc.
|
241,565 | $9,348,565 |
All Filings in NVAX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $292,576 | 35,943 | Shares | Sole | 2026-05-15 | |
| 2024-09-30 | $6,315,000 | 500,000 | Shares | Defined | 2024-11-25 | |
| 2024-06-30 | $8,018,983 | 633,411 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $172,156 | 36,016 | Shares | Defined | 2024-05-16 | |
| 2022-03-31 | $242,824 | 3,297 | Shares | Sole | 2022-05-20 | |
| 2021-12-31 | $409,180 | 2,860 | Shares | Sole | 2022-02-16 | |
| 2021-09-30 | $502,934 | 2,426 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $429,290 | 2,022 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||